Clinical Trials Browser

Phase 1/2 × Lung Neoplasms × capivasertib × Clear all

NCT07486648 2026-03-24

Precision

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms